Analytical Data
-
Gene name
GLMP
- Application
-
Alternative Names
C1orf85; NCU-G1; Lysosomal protein NCU-G1
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9JHJ3
-
Expression Region
Pro246~Asn404
-
Molecular Weight
45kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GLMP (Glutamate-like protein) is an emerging protein of interest in the field of molecular biology and biotechnology, particularly due to its potential roles in neurobiology and signal transduction. This recombinant protein has raised significant research interest because it is implicated in various physiological processes, including neurotransmission and cellular signaling pathways, which are crucial for understanding neurodegenerative diseases and mental health disorders. The ability to express GLMP as a recombinant protein enables researchers to dissect its structure-function relationships, identify its binding partners, and elucidate its biological effects in various cellular contexts. Moreover, advances in recombinant DNA technology allow for the optimization of GLMP production in various expression systems, providing a platform for both functional studies and potential therapeutic applications. The exploration of GLMP’s properties can facilitate the development of novel biomolecular tools and therapeutic strategies, particularly in targeting neurological conditions where glutamate signaling is dysregulated, making it a vital area of investigation in contemporary biomedical research.
